South Korea-based healthcare startup AIRS Medical announced today that it raised approximately $20 million in a Series B funding round.
New investors Q Capital Partners and Hanwha Life joined the round, which also included participation from Klim Ventures, which contributed to AIRS Medical’s Series A round.
AIRS Medical, which was co-founded by Seoul National University graduates in 2018, develops digitalized, AI-based diagnostic tests and robotics technologies aimed at providing a better clinical experience for both patients and healthcare providers, according to a news release.
The SwiftMR artificial intelligence (AI)-powered magnetic resonance imaging (MRI) reconstruction software has been developed and commercialized, the company said. AIRS Medical designed the platform to enhance MR images acquired under various conditions to offer a higher level of data accuracy and a better patient experience.
SwiftMR has FDA and Korea Ministry of Foo…